ADAR1 Capital Management »

Kalvista Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $119k 10k 11.86

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Tang Capital Management
Suvretta Capital Management
Vestal Point Capital
Frazier Life Sciences Management
Capital World Investors
BlackRock
BlackRock
Vanguard Group
Boxer Capital
Dr. Jeffrey R. Jay, M.D.
Saturn V Capital Management
MPM Oncology Impact Management
Emerald Advisers
Geode Capital Management

View all funds holding Kalvista Pharmaceuticals